The markets extended its losses during the midday with the Dow plummeting 128 points to 17,440 after Chinese markets plunged. Nasdaq tumbled 46 points to 5,042.
On the upside
Nymox Pharmaceutical (Nasdaq: NYMX) reported positive results from a Phase 3 study of NX-1207.
Celator Pharmaceuticals (Nasdaq: CPXX) presented this morning at the 42nd Annual Meeting and Exposition of the Controlled Release Society.
Oppenheimer initiated coverage of Pieris Pharmaceuticals (Nasdaq: PIRS) with an Outperform rating.
On the downside
Shares of TrueCar (Nasdaq: TRUE) continued falling.
Bellerophon Therapeutics (Nasdaq: BLPH) reported disappointing results from a PRESERVATION I clinical trial for Bioabsorbable Cardiac Matrix.
Shares of Peabody Energy (NYSE: BTU) fell ahead of its earnings release tomorrow morning before market open.
In the broad market, declining issues outpaced advancers by a margin of 7 to 3 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 fell 10 points to 2069. Bitcoin eased a fraction to $288.
Losses extended as Chinese markets plunge
July 27, 2015 at 15:38 PM EDT